Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	50	non-cytoplasmic
51	74	transmembrane
75	82	cytoplasmic
83	102	transmembrane
103	105	non-cytoplasmic
106	106	transmembrane
107	107	non-cytoplasmic
108	130	transmembrane
131	142	cytoplasmic
143	164	transmembrane
165	176	non-cytoplasmic
177	198	transmembrane
199	256	cytoplasmic
257	279	transmembrane
280	294	non-cytoplasmic
295	315	transmembrane
316	326	cytoplasmic
327	345	transmembrane
346	350	non-cytoplasmic
351	375	transmembrane
376	385	cytoplasmic
386	404	transmembrane
405	414	non-cytoplasmic
415	435	transmembrane
436	469	cytoplasmic

Input:
>NP_347967.1 NCBI__GCF_000008765.1:NP_347967.1
MGENNSHKHSLLFIVLISCAAGLGGLLYGYDTAVISGAIGFLKKLYNLSPAMQGFVISSI
MVGGVLGVGFSGFLGDAIGRRKVLMLAAALFAISAVISSISTSAFMLIFARIVGGLGIGM
ASALSVTYITECAPPSIRGRLSSLYQLFTILGISITFFVNLGIVNMGSETWRVSTGWRYM
LACGTVPAIVFLITLFFVPESPRFLVKSGNIKKAAAVLTKINGAEIAKQELDSISKSLAT
ENDSSLGQLLQPGLRRALLIGIFLAIFNQAIGMNSITYYGPEIFQMIGFKNNSSFLATSV
IGVVEVFSTILAMFLIDKLGRKKLMEIGSAAMAVFMLLIGTSFYIKLSNGFVILIFIICF
VVSFCISMGPIPWIMIPEIFPNHLRARATGIATIFLWGANWAIGQFTPMLLNGIGGAYTF
WIFCGINVICFLVVTTKVPETKNKSLEEIEKFWIPKSKQNAKGSSVGAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server